The Clinical Management of Type 2 Gaucher Disease

Molecular Genetics and Metabolism - United States
doi 10.1016/j.ymgme.2014.11.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Glucocerebrosidase 2 Gene Deletion Rescues Type 1 Gaucher Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Neonatal Cholestasis as Initial Manifestation of Type 2 Gaucher Disease: A Continuum in the Spectrum of Early Onset Gaucher Disease

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2011English

High Incidence of Cholesterol Gallstone Disease in Type 1 Gaucher Disease: Characterizing the Biliary Phenotype of Type 1 Gaucher Disease

Journal of Inherited Metabolic Disease
Genetics
2010English

Glucosylsphingosine Accumulation in Type 2 Gaucher Disease Begins Early in Gestation

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Management of Neutralizing Antibody to Ceredase in a Patient With Type 3 Gaucher Disease

Pediatrics
Child HealthPediatricsPerinatology
1997English

Long-Term Clinical Outcomes in Type 1 Gaucher Disease Following 10 Years of Imiglucerase Treatment

Journal of Inherited Metabolic Disease
Genetics
2012English

Gaucher Disease Type I Complicated With Parkinson's Syndrome

Haematologia
2002English

Impact of Imiglucerase Supply Constraint on the Therapeutic Management and Course of Disease in French Patients With Gaucher Disease Type 1

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Psy51 - Clinical and Economic Aspects of Enzyme Replacement Therapy in Russian Patients With Gaucher Disease Type 1

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy